In Estrogen Research, Challenge Is To Cull Good From Bad

What to make of estrogen? Does the female sex hormone's potential to protect women, and even men, against an array of illnesses foreshadow a research bonanza? Or will its use, in natural and synthetic forms, always be compromised by serious side effects, including an increased risk of cancer? A steady flow of academic articles and announcements from university research centers indicates widespread interest in such questions, but the asking seems much easier than the answering. "Estrogen" is a

Written bySteve Bunk
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"Estrogen" is a generic term for synthetic substances and a family of natural hormones formed by the ovary, placenta, and testes; possibly by the adrenal cortex; and by certain plants. In the United States, estrogen replacement therapy generally derives from a mixture of natural hormones obtained from the urine of pregnant mares. Despite estrogen's well-established ability to protect against osteoporosis and cardiovascular disease, less than one-fifth of postmenopausal women ever take estrogen supplements (L.M. Salamone et al., Archives of Internal Medicine, 156:1293-7, 1996). They, and their physicians, are wary not only of such frequent side effects as vaginal bleeding and breast swelling and tenderness, but also of the higher risk of breast and endometrial or uterine cancer. Progesterone often is prescribed along with estrogen to blunt the latter's carcinogenic potential, but progesterone may adversely affect the cardiovascular system. In recent years, research into estrogen has yielded evidence of its possible ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies